|
Jun 5
|
Q1 Earnings Roundup: PacBio (NASDAQ:PACB) And The Rest Of The Life Sciences Tools & Services Segment
|
|
Jun 2
|
Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date
|
|
May 28
|
PacBio to Present at Upcoming Investor Conferences
|
|
May 26
|
3 Out-of-Favor Stocks Skating on Thin Ice
|
|
May 22
|
PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene
|
|
May 14
|
1 Russell 2000 Stock with Exciting Potential and 2 to Approach with Caution
|
|
May 12
|
PacBio Board Independent Investigation Concludes Allegations Unsubstantiated
|
|
May 10
|
Pacific Biosciences of California First Quarter 2025 Earnings: EPS Misses Expectations
|
|
May 9
|
PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates
|
|
May 9
|
Pacific Biosciences (PACB) Reports Q1 Earnings: What Key Metrics Have to Say
|
|
May 8
|
PacBio (NASDAQ:PACB) Beats Expectations in Strong Q1
|
|
May 8
|
Pacific Biosciences: Q1 Earnings Snapshot
|
|
May 8
|
PacBio Announces First Quarter 2025 Financial Results
|
|
May 7
|
PacBio (PACB) Q1 Earnings: What To Expect
|
|
May 5
|
First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand
|
|
Mar 14
|
Pacific Biosciences of California (PACB) Increases Yet Falls Behind Market: What Investors Need to Know
|
|
Mar 11
|
1 Healthcare Stock to Target This Week and 2 to Turn Down
|
|
Feb 19
|
PacBio to Participate in TD Cowen's 45th Annual Health Care Conference
|
|
Feb 15
|
PacBio should return to growth over time, says Canaccord
|
|
Feb 15
|
Pacific Biosciences of California Full Year 2024 Earnings: EPS Beats Expectations
|